Cite
663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis
MLA
Faisal Khan, et al. “663 Correlation between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis.” Journal for ImmunoTherapy of Cancer, vol. 8, no. Suppl 3, Nov. 2020. EBSCOhost, https://doi.org/10.1136/jitc-2020-SITC2020.0663.
APA
Faisal Khan, Shameer Khader, Youyi Zhang, Daniel Jackson, Kirsty Rhodes, Imran Khan Anwer Neelufer, Sreenath Nampally, Andrzej Prokop, Emmette Hutchison, Jiabu Ye, Feng Liu, Antony Sabin, James Weatherall, Cristina Duran, Renee Iacona, & Pralay Mukhopadhyay. (2020). 663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis. Journal for ImmunoTherapy of Cancer, 8(Suppl 3). https://doi.org/10.1136/jitc-2020-SITC2020.0663
Chicago
Faisal Khan, Shameer Khader, Youyi Zhang, Daniel Jackson, Kirsty Rhodes, Imran Khan Anwer Neelufer, Sreenath Nampally, et al. 2020. “663 Correlation between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis.” Journal for ImmunoTherapy of Cancer 8 (Suppl 3). doi:10.1136/jitc-2020-SITC2020.0663.